Q: Back in the glory days of PHM, CXR, VRX etc I feel like everyone was looking for "doubles". Expectations seem more modest (pot stocks excepted) these days but I am wondering if 5i could highlight 3 stocks in Canada and 3 in the US that have the fundamentals to suggest a possible double in 2019/2020? If you have time, a few words on the expected catalyst for each as to why the runway is long? Deduct credits as required to provide a full reply please.
Q: I own MRE and up about 15% and was thinking about selling with all the noise regarding peek auto, electrification etc...on the other hand it is cheap on P/E basis. What do you think? Also do you provide moving averages as part of your reports on the stocks you cover?
Q: I would like your opinion on this stock. They are starting to get alot of orders for the crystals they make and expanded their production facilities but I don't know about the financials.
Could you give me your current analysis of this company. They appear to be in the right space.
Looking at taking an initial position in my tfsa. Would you recommend at today's price.
Thanks for all your objective work!!
Q: Can I get your thoughts on the recent announcement of "Intrinsyc’s engagement of Roth Capital Partners, LLC (“Roth”) as a financial advisor with a mandate to accelerate strategic growth opportunities for the Company. The goal of Roth’s mandate, which has been documented by a formal engagement agreement on standard industry terms, is to enhance value for all holders of Intrinsyc common shares."
Q: What is your take on PLI?? At current prices has this become another risky, penny stock or is there some upside over the next year or two. Does it have any future potential for capital gain?? Thanks for your thoughts
Q: Which of either Sylogist,(syz) or Absolute Software, (abt) do you prefer for growth for a 3/5 year horizon. I recognize that they are in different technological fields, but am leaning slightly toward Absolute.
I don't see any questions on this company Cardiol Therapeutics Inc. (CRDL) that did a recent IPO on TSX and hit a 52 week high today. It seems they are in a (speculative) cannabinoid arena with some drugs coming into phase 1 stages in 2019.
What is management history (CEO, CFO, etc.), board of directors, ...ie are they a solid team?
They had a string of announcements (LOI's, exclusive agreements, etc) in 2017 but no real follow-up news in 2018 wrt these signings.
Does their product pipeline seem promising?
How might it compare to Cannimed wrt therapeutic applications?
Is it a company to just watch for now given it's very recent IPO? So many IPO's flop in the first 6 months thus the caution.
Q: Could you please give us an update on this company. The farm bill legalized Hemp Will this have any affect on Hempco I need to decide whether this is a buy sell or hold
Q: Hi folks,
Do you see ATE's bought deal positively because the company is setting the stage for Phase 3 development, or negatively because the company has yet to attract big pharma interest? Would you consider the current price weakness a buying opportunity or just another dilution?
Thanks,
Glen